108 results
Page 4 of 6
8-K
EX-1.1
x4fr9hwfqau1q37r
18 Dec 20
Arvinas, Inc. Announces Pricing of $400 Million Public Offering of Common Stock
6:30am
424B5
1k1y02n
16 Dec 20
Prospectus supplement for primary offering
4:01pm
424B5
txpy5xnv
14 Dec 20
Prospectus supplement for primary offering
4:48pm
S-3ASR
lin6g93yvxzi 2cy5ap
14 Dec 20
Automatic shelf registration
4:02pm
S-3ASR
EX-4.6
al5d43 5g9zj
14 Dec 20
Automatic shelf registration
4:02pm
S-3ASR
EX-4.5
x4lnnlksy6p u6ic
14 Dec 20
Automatic shelf registration
4:02pm
8-K
EX-99.1
awjvqbzvblsj9k00h
14 Dec 20
Regulation FD Disclosure
7:30am
8-K
EX-99.1
smx6qvp clt7apx0ku
14 Oct 20
Other Events
7:00am
8-K
EX-99.1
m5f r762x5kiow0g5gu
29 May 20
Arvinas Releases Updated Dose Escalation Data from Clinical Trial of PROTACĀ® Protein Degrader
7:06am
8-K
EX-1.1
uhe8ub jq
12 Nov 19
Arvinas, Inc. Announces Pricing of Public Offering of Common Stock
4:02pm
424B5
f3ofg1 s73
7 Nov 19
Prospectus supplement for primary offering
4:05pm